Cargando…

Successful Treatment with Osimertinib Based on Therapeutic Drug Monitoring in a Hemodialysis Patient with Non-Small Cell Lung Cancer: A Case Report

Although osimertinib is a key drug in the treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation, the safety in hemodialysis patients has not been established. A 76-year-old man was diagnosed with NSCLC with EGFR deletion mutation in exon 19. After trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabata, Keisuke, Aoki, Masaya, Miyata, Ryo, Umehara, Tadashi, Harada-Takeda, Aya, Kamimura, Go, Nagata, Toshiyuki, Okizono, Ryuya, Terazono, Hideyuki, Takeda, Yasuo, Suetsugu, Takayuki, Ueda, Kazuhiro, Sato, Masami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626281/ https://www.ncbi.nlm.nih.gov/pubmed/37936662 http://dx.doi.org/10.1159/000531840

Ejemplares similares

A case of ectopic cervical thymoma with myasthenia gravis mimicking a parathyroid tumour
por: Kamimura, Go, et al.
Publicado: (2022)

Tumor enucleation for Castleman’s disease in the pulmonary hilum: a case report
por: Aoki, Masaya, et al.
Publicado: (2019)

Computed tomography-guided thoracoscopic debridement for multiple loculated organizing empyema: a case report
por: Aoki, Masaya, et al.
Publicado: (2019)

Clinical significance of ALKBH4 expression in non-small cell lung cancer
por: Aoki, Masaya, et al.
Publicado: (2022)

A case of schwannoma at the origin of the right recurrent laryngeal nerve resected under uniportal video‐assisted thoracic surgery
por: Kamimura, Go, et al.
Publicado: (2022)

Computed tomography of an air-inflated resected lung is useful for verifying the intraoperative findings of complete resection in a reduction operation
por: Kamimura, Go, et al.
Publicado: (2023)

Human lymph node degeneration in the thoracic region: A morphometric and immunohistochemical analysis using surgically obtained specimens
por: Jin, Zhe-Wu, et al.
Publicado: (2022)

Expression of Bone Morphogenetic Protein-7 Significantly Correlates With Non-small Cell Lung Cancer Progression and Prognosis: A Retrospective Cohort Study
por: Aoki, Masaya, et al.
Publicado: (2019)

A case of intradiaphragmatic bronchogenic cyst with an abnormally high serum level of CA19‐9
por: Kamimura, Go, et al.
Publicado: (2021)

Successful closure of a tracheocutaneous fistula after tracheostomy using two skin flaps: a case report
por: Watanabe, Yui, et al.
Publicado: (2015)

An extremely rare case with right superior pulmonary vein translocation
por: Kamimura, Go, et al.
Publicado: (2020)

Four-dimensional flow magnetic resonance imaging study to explain high prevalence of pulmonary vein stump thrombus after left upper lobectomy
por: Umehara, Tadashi, et al.
Publicado: (2020)

MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
por: Hirono, Takayuki, et al.
Publicado: (2019)

ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer
por: Jingushi, Kentaro, et al.
Publicado: (2021)

High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction
por: Takahashi, Takayuki, et al.
Publicado: (2021)

Left atrial CT volume and CHA(2)DS(2)-VASc score predict early pulmonary vein stump thrombus after left upper lobectomy
por: Takumi, Koji, et al.
Publicado: (2023)

Intraoperative cone-beam computed tomography to secure the surgical margin in pulmonary wedge resection for indistinct intrapulmonary lesions
por: Ueda, Kazuhiro, et al.
Publicado: (2022)

Osimertinib administration via nasogastric tube in an EGFR‐T790M‐positive patient with leptomeningeal metastases
por: Takeda, Takayuki, et al.
Publicado: (2017)

Why does pulmonary vein thrombus predominantly develop after left upper lobectomy?
por: Umehara, Tadashi, et al.
Publicado: (2021)

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report
por: Saito, Zentaro, et al.
Publicado: (2023)

Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic/Pharmacodynamic Study
por: Umezaki, Yasuhiro, et al.
Publicado: (2022)

Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR
por: Sakai, Hitomi, et al.
Publicado: (2017)

First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?
por: Takeda, Masayuki, et al.
Publicado: (2019)

TAPO in first‐line osimertinib therapy and continuation of osimertinib
por: Mimura, Chihiro, et al.
Publicado: (2022)

Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
por: Fukuda, Yuko, et al.
Publicado: (2022)

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report
por: Kano, Yukari, et al.
Publicado: (2022)

Successful Re-administration of Osimertinib in Osimertinib-induced Interstitial Lung Disease with an Organizing Pneumonia Pattern: A Case Report and Literature Review
por: Itano, Junko, et al.
Publicado: (2019)

Three-incision robotic major lung resection for cancer
por: Ueda, Kazuhiro, et al.
Publicado: (2021)

Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin
por: Minezumi, Takumi, et al.
Publicado: (2018)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

Osimertinib-Induced Cardiomyopathy
por: Patel, Shruti R., et al.
Publicado: (2020)

Osimertinib‐related liver injury with successful osimertinib rechallenge: A case report
por: Cheng, Yuan‐Ling, et al.
Publicado: (2022)

Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to Osimertinib
por: Makimoto, Go, et al.
Publicado: (2019)

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
por: Morimoto, Kenji, et al.
Publicado: (2022)

Treatment of EGFR mutation–positive non–small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report
por: Nonagase, Yoshikane, et al.
Publicado: (2018)

Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma
por: Satoh, Shingo, et al.
Publicado: (2017)

Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease
por: Kiriu, Tatsunori, et al.
Publicado: (2017)

Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
por: Nishii, Kazuya, et al.
Publicado: (2021)

Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
por: Kawaguchi, Yo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_icrctk9ke0sph0cc6r2qe4g7rd